Velaglucerase alfa regulatory update

FDA accepted for filing and granted Priority Review to an NDA from Shire for velaglucerase alfa to treat Type 1 Gaucher's disease. The PDUFA date is Feb. 28, 2010. The company plans to submit an MAA f...